Read the latest positive news, breakthroughs, and inspiring stories about stem cell therapy, curated daily by BrightWire.
Singapore biotech companies are expanding into China to tap into massive healthcare needs and faster research timelines. The move could speed up life-saving treatments for millions of diabetes and liver cancer patients.
University of Miami researchers have mapped a promising path forward for stroke patients who don't fully recover despite current treatments. A new stem cell therapy delivered directly to the brain could help patients regain independence after strokes.
Scientists at the University of Miami are pioneering a method to deliver stem cells directly into brain arteries, offering new hope for stroke survivors facing disability. Early trials show the approach is safe and could become the next breakthrough in stroke recovery.
For the first time in medical history, Chinese scientists have completely reversed type 2 diabetes using stem cell therapy, freeing patients from insulin injections. A 59-year-old man has lived medication-free for nearly three years after receiving lab-grown pancreatic cells made from his own blood.
Patients with severe heart failure in Japan can now access a revolutionary treatment that uses lab-grown heart cells to repair damaged hearts. The breakthrough therapy is only the second stem cell product covered by public insurance in the country.
After 25 years of research, scientists have successfully transplanted stem cells into patients' brains that survived, produced dopamine, and dramatically reduced Parkinson's symptoms. One approach just received FDA approval to begin the final trial phase before potential release to patients.
A Boston biotech firm is using artificial intelligence to fast-track stem cell treatments for Parkinson's disease, potentially cutting years off development time. The breakthrough could bring hope to millions living with the condition.
A Japanese startup just treated a heart failure patient using a simple catheter instead of open-heart surgery, injecting lab-grown heart muscle cells that could transform cardiac care. The patient in his 70s has already gone home.
Australia's leading children's research institute just secured $5 million in federal funding to prevent childhood diseases. The announcement came during the institute's 40th anniversary celebration, alongside news of a $200 million endowment fund.
Mount Sinai researchers made old blood stem cells behave like young ones again by repairing tiny cellular recycling centers, boosting their regenerative power eightfold. This discovery could lead to treatments that help elderly people maintain healthier immune systems and reduce risks of blood disorders.
Australia has become the first country outside the US to approve a revolutionary therapy for chronic graft-versus-host disease, a serious complication affecting nearly half of blood cancer patients who receive donor stem cell transplants. The treatment was developed from world-first research led by Australian scientists over a decade ago.
A Florida biopharmaceutical company just hit a major milestone in making regenerative medicine safer and more trustworthy. ZEO ScientifiX has now trained over 500 doctors on how to use stem cell therapies responsibly.